COMP and diabetic retinopathy: Alternatively, adenoviral delivery (AAV2) of a recombinant version of ANG‐1, called COMP‐ANG‐1, demonstrated a protective function of ANG‐1 in models of choroidal neovascularization and diabetic retinopathy (Cahoon et al, 2015; Lambert et al, 2016).